LRRK2 and Parkinson disease: It was specifically mentioned as follows; “Altogether, it could be assumed that the dysregulation of CPNE8, CADPS2, or UHRF2 contributes to PD progression via ERK activation induced by the LRRK2 G2019S mutation”.